Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 5 min ago
PreprintCC BYmedRxiv

Global immuno-epidemiology and the persistence of mpox clade IIb in MSM

  1. 1Freie Universität Berlin, Robert Koch-Institut

Abstract

In 2022, mpox clade IIb spread globally in men who have sex with men (MSM) via sexual contact. By summer 2022, case numbers declined in Europe and Norther America due to behavior change and immunization, with almost no reported cases in 2023, followed by low-level transmission. By autumn 2022, many susceptible individuals at high risk of transmission may have become immunized. Moreover, because individuals with mpox are infectious for only 2-4 weeks, sustaining transmission chains requires considerable infection throughput. This raises the question: How did mpox persist and transition to endemic circulation?

We developed an agent-based model of mpox transmission on the Berlin MSM sexual contact network that incorporates viral shedding kinetics, vaccination, infection-derived immunity, immune waning, and case importations. After calibrating the model, we estimated that the probability of mpox extinction in Berlin exceeded 80% in 2023, when acquired immunity fragmented the transmission network. Extending the analysis to a European MSM metapopulation reduced the extinction probability to less than 60%, whereas incorporating global metapopulation dynamics reduced it to nearly zero. We find that mpox persistence was enabled by epidemic asynchrony: When transmission declined in Europe/the Americas, mpox transmission continued in Asia, long enough for immune waning to partially restore transmission potential in Europe, thereby enabling subsequent re-importation and endemic circulation. These model-based findings are supported by phylogenetic evidence indicating that all active German transmission clusters are either linked to (i) re-importation of clade F from the Americas, or (ii) the emergence of clades C and E linked to Asia.

Our findings on asynchronous transmission across connected global MSM networks highlight the role of global immuno-epidemiology in enabling mpox persistence and emphasize the importance of coordinated international surveillance and control efforts.

Related

  1. Tell people and lose what I have: Care-seeking, concealment, and disclosure during Sierra Leone’s 2025 clade IIb mpox outbreak
    Eric Nzirakaindi Ikoona, Lucy Namulemo, Mary Magdalene Sinnah +2
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthInfectious diseasePLOS
  2. Paediatric mpox during Sierra Leone’s 2024 to 2025 clade IIb outbreak: A national surveillance and outbreak-investigation study of 415 children
    Eric Nzirakaindi Ikoona, Lucy Namulemo, Mary Magdalene Sinnah +2
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BYFull textImmunologyMicrobiologyPLOSEurope PMC
  3. Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integration
    Jingna Wu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  4. Global mpox outbreak dynamics during and after the 2024–2026 public health emergency
    Tambe Elvis Akem
    PLOS OnePeer-reviewedCC BYFull textEpidemiology & public healthPLOSEurope PMC
  5. The Global Epidemiology of Tuberculosis: Burden, Trends, and Determinants
    Gerhard Walzl, Delia Goletti, Alimuddin Zumla
    Cold Spring Harbor Perspectives in MedicinePreprintLicence not statedFull text9 citedInfectious diseasePMC
BibTeX
@misc{gubela2026global,
  title = {{Global immuno-epidemiology and the persistence of mpox clade IIb in MSM}},
  author = {N. Gubela and R. Berghold and A. Bartel and D. Kühnert and M. von Kleist},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.16.26363229},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.16.26363229v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Global immuno-epidemiology and the persistence of mpox clade IIb in MSM
AU  - N. Gubela
AU  - R. Berghold
AU  - A. Bartel
AU  - D. Kühnert
AU  - M. von Kleist
PY  - 2026
DA  - 2026/09/16
PB  - medRxiv
DO  - 10.64898/2026.09.16.26363229
UR  - https://www.medrxiv.org/content/10.64898/2026.09.16.26363229v1
AB  - In 2022, mpox clade IIb spread globally in men who have sex with men (MSM) via sexual contact. By summer 2022, case numbers declined in Europe and Norther America due to behavior change and immunization, with almost no reported cases in 2023, followed by low-level transmission. By autumn 2022, many susceptible individuals at high risk of transmission may have become immunized. Moreover, because individuals with mpox are infectious for only 2-4 weeks, sustaining transmission chains requires considerable infection throughput. This raises the question: How did mpox persist and transition to endemic circulation?  We developed an agent-based model of mpox transmission on the Berlin MSM sexual contact network that incorporates viral shedding kinetics, vaccination, infection-derived immunity, immune waning, and case importations. After calibrating the model, we estimated that the probability of mpox extinction in Berlin exceeded 80% in 2023, when acquired immunity fragmented the transmission network. Extending the analysis to a European MSM metapopulation reduced the extinction probability to less than 60%, whereas incorporating global metapopulation dynamics reduced it to nearly zero. We find that mpox persistence was enabled by epidemic asynchrony: When transmission declined in Europe/the Americas, mpox transmission continued in Asia, long enough for immune waning to partially restore transmission potential in Europe, thereby enabling subsequent re-importation and endemic circulation. These model-based findings are supported by phylogenetic evidence indicating that all active German transmission clusters are either linked to (i) re-importation of clade F from the Americas, or (ii) the emergence of clades C and E linked to Asia.  Our findings on asynchronous transmission across connected global MSM networks highlight the role of global immuno-epidemiology in enabling mpox persistence and emphasize the importance of coordinated international surveillance and control efforts.
ER  -